Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
10/2005
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1307431B1 Efficient ligand-mediated ullmann coupling of anilines and azoles
10/26/2005EP1163234B1 Pharmaceutical formulations with improved aqueous solubility
10/26/2005CN1688573A Pyrrole based inhibitors of glycogen synthase kinase 3
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958353 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
10/25/2005US6958348 Side effect reduction
10/25/2005US6958339 Pyrazole derivative
10/25/2005US6958337 Crystalline antifungal polymorph
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/25/2005CA2059882C Sulfonylureas
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234055 Pyrazole derivative
10/19/2005EP1585744A1 Process for making ondansetron and intermediates thereof
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP0966446B1 Bicyclic inhibitors of protein farnesyl transferase
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/19/2005CN1223564C Intermediate halo phenyl derivatives and their use in process for preparing pyrrole derivatives
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005CA2307581C Heterocyclic compounds having nos inhibiting action
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228020 Beta secretase inhibitors
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050226844 Valency platform molecules comprising carbamate linkages
10/12/2005EP1583742A1 Novel cb 1 receptour inverse agonists
10/12/2005CN1681788A COX-2 inhibiting pyridine derivatives
10/12/2005CN1681763A Chemical compounds
10/11/2005US6953807 4-substituted-picolinic acid amide derivatives useful as fungicides
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222411 Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates
10/06/2005US20050222226 N-[3-(2-Aminoethyl)-4-(4-bromophenyl)thiazol-2(3H)-ylidene]aniline; antiinflammatory agents, antiallergens; inhibit infiltration of leukocytes such as eosinophils and lymphocytes; autoimmune diseases, asthma
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678576A Pyrrolidine derivatives as oxytocin antagonists
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/04/2005US6951886 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
10/04/2005US6951879 Heteroaromate OSC inhibitors
10/04/2005US6951574 Primary intermediates for oxidative coloration of hair
09/2005
09/29/2005WO2005046688A3 Methods of use of thrombin receptor antagonists
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/28/2005EP1233936B1 Process for preparing ambient temperature ionic liquids
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/28/2005CN1220684C 2, 4, Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/22/2005US20050209466 Reproducible; avoids use of 3-pyrrolidinol as a starting material
09/22/2005US20050209291 Amino benzothiazole compounds with NOS inhibitory activity
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005CN1671717A Azole derivatives as antifungal agents
09/21/2005CN1671670A Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/20/2005US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946460 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine;
09/20/2005US6946005 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/14/2005EP1572694A1 Pyrrolo'2,1-c!'1,4! benzodiazepines as vasopressin agonists
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005US6943161 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/13/2005CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/13/2005CA2078700C Imidazolylmethyl-pyridines
09/07/2005EP1569921A1 Ionic liquids comprising n(cf sb 3 /sb ) sb 2 /sb ] sp - /sp anions
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005CN1665788A Pyrimidinone compounds, compositions and methods
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217928C Heterocyclic compounds having NOS inhibitory activities
09/06/2005US6939974 Heating an imidazolium halide with a strong base under reduced pressure and separating the resultant products
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/01/2005WO2004054991A8 Ionic liquids comprising [n(cf3)2]- anions
09/01/2005US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
08/2005
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005CN1662525A Preparation for the production of 1, 2, 4-triazolymethyl-oxiranes
08/31/2005CN1662518A Processes for producing epoxytriazole derivative and intermediate therefor
08/31/2005CN1660798A Processes for preparing aminophenylsulfonylureas, and intermediates therefor
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1292190B1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
08/24/2005CN1216054C 1,4-dihydro pyridine-3,5-carboxylic-acid derivatives and preparation method thereof
08/23/2005US6933311 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005CA2370888C Renin inhibitors
08/18/2005WO2005075422A1 Synthesis methods and intermediates for the manufacture of rizatriptan
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005CA2553652A1 Synthesis methods and intermediates for the manufacture of rizatriptan
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 163